Repligen (RGEN) Common Equity (2009 - 2026)
Repligen's Common Equity was $2.09 billion in Q3 2026, up 0.4% from $2.08 billion a year earlier but down 1.0% from the prior quarter.
Powered by 
Analysis
Repligen (RGEN) Common Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Repligen came in at $2.11 billion, up 6.8% from FY2024.
- Common Equity has now increased for 12 consecutive years, with a five-year compound annual growth rate of 6.6% (FY2020 to FY2025).
- In earlier years, Common Equity was $1.97 billion in FY2024 (+0.4%), $1.96 billion in FY2023 (+2.8%), $1.91 billion in FY2022 (+9.2%) and $1.75 billion in FY2021 (+14.4%).
- Quarterly Common Equity has moved between $1.75 billion (Q4 2021) and $2.11 billion (Q2 2026) over five years.
- Compared with a year earlier, Common Equity has increased for 51 straight quarters, with growth averaging 3.0% over the last eight quarters.
- Across the past five years, year-over-year growth in Common Equity ran from 0.4% in Q4 2024 to 14.4% in Q4 2021.
- Per Business Quant data, RGEN's Common Equity in the three quarters before Q3 2026 was $2.11 billion (Q2 2026), $2.11 billion (Q1 2026) and $2.11 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 259.44 Bn | 236.08 Bn | 5.13 Bn | 54.77 Bn |
| 2 | Abbott Laboratories | 187.98 Bn | 162.45 Bn | 7.39 Bn | 51.62 Bn |
| 3 | Danaher | 163.91 Bn | 143.58 Bn | 3.84 Bn | 53.63 Bn |
| 4 | Intuitive Surgical | 153.75 Bn | 134.17 Bn | 2.08 Bn | 16.12 Bn |
| 5 | Medtronic | 131.67 Bn | 97.80 Bn | 6.34 Bn | 50.85 Bn |
| 6 | Stryker | 117.84 Bn | 104.03 Bn | 4.25 Bn | 23.46 Bn |
| 7 | Boston Scientific | 64.27 Bn | 59.95 Bn | 3.43 Bn | 25.87 Bn |
| 8 | Edwards Lifesciences | 61.69 Bn | 45.00 Bn | 1.35 Bn | 10.96 Bn |
| 9 | Medline | 51.94 Bn | 49.07 Bn | 1.93 Bn | 19.39 Bn |
| 10 | Repligen | 9.51 Bn | 6.29 Bn | 110.99 Mn | 2.09 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.09 Bn |
| Jun 30, 2026 | 2.11 Bn |
| Mar 31, 2026 | 2.11 Bn |
| Dec 31, 2025 | 2.11 Bn |
| Sep 30, 2025 | 2.08 Bn |
| Jun 30, 2025 | 2.06 Bn |
| Mar 31, 2025 | 1.99 Bn |
| Dec 31, 2024 | 1.97 Bn |
| Sep 30, 2024 | 2.02 Bn |
| Jun 30, 2024 | 1.98 Bn |
| Mar 31, 2024 | 1.97 Bn |
| Dec 31, 2023 | 1.96 Bn |
| Sep 30, 2023 | 1.97 Bn |
| Jun 30, 2023 | 1.96 Bn |
| Mar 31, 2023 | 1.93 Bn |
| Dec 31, 2022 | 1.91 Bn |
| Sep 30, 2022 | 1.84 Bn |
| Jun 30, 2022 | 1.81 Bn |
| Mar 31, 2022 | 1.77 Bn |
| Dec 31, 2021 | 1.75 Bn |
API Access
Repligen Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=RGEN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "RGEN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=RGEN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();